Cytosorbents
CTSO
$0.82
Share price
1.24%
Change (1 day)
-66.71%
Change (1 year)
Categories
Cytosorbents (CTSO) - Total liabilities
Total liabilities on the balance sheet as of December 2023 : $29.98 M
According to Cytosorbents's latest financial reports the company's total liabilities are $29.98 M. A company’s total liabilities is the sum of all current and non-current debts and obligations.
Cytosorbents - Total liabilities on balance sheet (from 2005 to 2023)
Total liabilities by year
| Year | Total liabilities | Change |
|---|---|---|
| 2022-12-31 | $27.85 M | 3.4% |
| 2021-12-31 | $26.94 M | 150.97% |
| 2020-12-31 | $10.73 M | -55.2% |
| 2019-12-31 | $23.96 M | 38.83% |
| 2018-12-31 | $17.26 M | 24.72% |
| 2017-12-31 | $13.84 M | 65.63% |
| 2016-12-31 | $8.35 M | 174.54% |
| 2015-12-31 | $3.04 M | -32.44% |
| 2014-12-31 | $4.5 M | -75.4% |
| 2013-12-31 | $18.31 M | 22.36% |
| 2012-12-31 | $14.96 M | 22.53% |
| 2011-12-31 | $12.21 M | 431.79% |
| 2010-12-31 | $2.29 M | 136.57% |
| 2009-12-31 | $0.97 M | -5.54% |
| 2008-12-31 | $1.02 M | 13.32% |
| 2007-12-31 | $0.9 M | -16.19% |
| 2006-12-31 | $1.08 M |
Total liabilities for similar companies or competitors
| Company | Total liabilities | differencediff. | Country |
|---|---|---|---|
 Boston Scientific BSX | $15.60 B | 51,945.16% | 🇺🇸 USA |
 Hologic HOLX | $3.81 B | 12,625.15% | 🇺🇸 USA |
 Meridian Bioscience VIVO | $95.03 M | 216.94% | 🇺🇸 USA |